GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on ...

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more ...

M&A headlined for a second straight week as Genmab acquired Merus for $8 billion; Pfizer strikes most-favored-nation deal ...

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the ...

Emma Walmsley, who in 2017 became the first woman to lead a major pharmaceutical company, will step down from her post as CEO ...

Walmsley will step down from the board of directors of GSK at the end of the year, and will step down as CEO on 30th ...

GSK plc names new CEO as shares rise 3% and maintains a 4% dividend yield; get key insights on GSK stock's outlook and what ...

GSK has announced the departure of the pharmaceutical group’s first female chief executive, Dame Emma Walmsley after eight ...

Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke ...

Chief executive Emma Walmsley is to leave GSK, it was announced on Monday, after nearly a decade in the role. She will be ...

GSK is "betting big on the US" and engaged in "constructive" talks on drug pricing with President Donald Trump's ...